Connect with us


Pediatric Perfusion Market to Grow Tremendous CAGR by 2025 Profiling Top Key Players like Medivators, Terumo, Medtronic, Philips Benelux, GE Healthcare and More


Fortune Business Insights published a recent report titled “Pediatric Perfusion Market Size, Share and Global Trend By Product (Pediatric cannulae, Pediatric Centrifugal Blood Pumps, Pediatric Arterial Line Filters, Hemoconcentrators, HMS Plus Hemostasis Management System, Pediatric oxygenation systems), By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Others), and Geography Forecast till 2026.” explores rising demand for minimally invasive surgeries is also supporting the growth of the global pediatric perfusion market.

Browse Full Report @

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Pediatric Perfusion market. Some of the companies operating the global Pediatric Perfusion market are;

  • Medivators, a Cantel Medical Company LivaNova PLC
  • Terumo Cardiovascular Group
  • Medtronic
  • BL Lifesciences
  • Philips Benelux
  • GVM Care and Research
  • GE Healthcare
  • Terumo Medical Corporation

FDA Approves Affinity Pixie Oxygenation SystemMedtronic, a global leader in medical device received approval from the Food and Drug Admiration for its Affinity Pixie Oxygenation System. The CO2/O2exchange device will be used in cardiopulmonary bypass surgeries on, infants, small children and neonates. The system will offer a2.0 L/min maximum flow rate with initial priming of 48 mL, and the internals of the device are coated with Balance Biosurface, a hydrophilic surface that doesn’t use heparin in preventing blood clots. The launch of the device is predicted to promote pediatric perfusiontechniques owing to the device alongside the ability to warm or cool blood during the passing. This will, in turn, Encourage the growth of the global pediatric perfusion shares.

Get PDF Brochure of this [email protected]

Key Segmentation:

By Product

  • Pediatric cannulae
  • Pediatric Centrifugal Blood Pumps
  • Pediatric Arterial Line Filters
  • Hemoconcentrators
  • HMS Plus Hemostasis Management System
  • Pediatric oxygenation systems

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East and Africa (South Africa, GCC, and Rest of Middle East and Africa)

Increasing Demand for Non-Invasive Treatment Will Foster Growth Opportunities

Children of less than a year old commonly undergo open-heart surgeries due to heart defects that occur during birth such as ventricular septal defect (VSP) for instance according to Centers of Disease Control and Prevention (CDC), 16,800 babies in the U.S. are born with ventricular septal defect and one million children suffers from congenital heart defects which have elevated the demand for effective and non-invasive treatment methods to cure the heart defects. These factors are predicted to contribute growth to the pediatric perfusion revenue. Further, the rising cases of congenital heart disease and increasing awareness about the new treatment of various cardiac abnormalities are also contributing significantly to the global pediatric perfusion shares. Additionally, the increasing demand for minimally invasive and effective technological treatment along with the rising acceptance of pediatric perfusion technology to treat congenital heart disease are expected to accelerate the pediatric perfusion market during the forecast period. However, high cost associated with pediatric cardiac heart surgeries low-income nations is projected to hamper the growth in global pediatric perfusion market during the forecast period.

Increasing Cases of Heart Diseases Will Encourage Growth in North America

Geographically, the global pediatric perfusion market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America leads the global market and is predicted to dominate in the forthcoming year. Product launches by many key players and increasing prevalence of heart disease in children are likely to aid growth in the region. The increasing demand for effective technologies used during heart surgeries is also likely to support the growth of the global pediatric perfusion system market in North America during the forecast period. The market in the Asia Pacific is predicted to grow at a considerable rate owing to the growing patient population and surge in RandD investments activities by many healthcare organizations.

See our Related Reports:

Power and Cost Savings to Drive Contraceptive Devices Market Trend | Fortune Business Insights

Contraceptive Devices Market 2019 Global Industry Size, Growth Factor Analysis Research Report 2025

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


PlanetWatch activates innovative air quality monitoring in two key Italian cities and announces grant from the Algorand Foundation


ST. GENIS-POUILLY, France, Oct. 28, 2020 /PRNewswire/ — PlanetWatch, a French startup which is leveraging the Algorand blockchain to build a global air quality ledger, announced today that it has already activated over 100 sensors in the Italian cities of Milan and Taranto.

PlanetWatch builds its global air quality monitoring network by combining city specific partnership networks and the creation of a global community of individual air sensor owners.

Fast and seamless sensor deployment in these cities was achieved thanks to strong partnerships with Wiseair in Milan, a citizen association in Taranto and support from a grant from the Algorand Foundation.

C. Parrinello, PlanetWatch’s CEO said:

"The activation of dense sensor networks in Taranto and Milan is a major milestone for PlanetWatch. We are delivering cost-effective air quality monitoring solutions for cities worldwide. By leveraging citizen communities and associations, together with corporate partners and advanced technologies, we believe we can raise the standards of environmental monitoring and help protect public health. We are very grateful to the Algorand Foundation, Wiseair srl and the Taranto citizen association for their support towards our endeavours."

"We are delighted to support PlanetWatch in their global air quality monitoring network," said Sean Lee, CEO of the Algorand Foundation. "By building on a blockchain with the speed and scale of Algorand, PlanetWatch can be confident that as their network scales to millions of devices and daily measurements, Algorand will be able to comfortably handle data volumes, while making the data accessible to all."

C.A. Gaetaniello, Wiseair’s COO said:

"Wiseair’s mission is to involve urban communities in air quality monitoring to promote a clean air future. With the support of the Wiseair community, we distributed more than 100 air quality sensors all over the city. Thanks to our strong partnership with PlanetWatch the data collected will be validated and made accessible to all. Citizen science and technology are combined here to build a new model to fight against air pollution."

S. Fersini from Comitato Cittadini e Lavoratori Liberi e Pensanti said: "We advocate the closure of all highly polluting industrial plants in our city and we hope that these monitoring activities and subsequent developments will help studying the connection between the excess of diseases linked to pollution and industrial production and the need for change in European environmental legislation on allowed emissions."

PDF –  
Logo –

Claudio Parrinello, CEO
[email protected]


Related Links :

Continue Reading


Atlas Crest Investment Corp. Announces Pricing of $500 Million Initial Public Offering


October 27, 2020 — Atlas Crest Investment Corp. (NYSE: ACIC.U, the “Company”) announced today that it priced its initial public offering of 50,000,000 units at a price to the public of $10.00 per unit. The units are expected to commence trading on October 28, 2020 on The New York Stock Exchange (the NYSE) under the ticker symbol “ACIC.U”. Each unit consists of one share of Class A common stock and one-third of one warrant, each whole warrant entitling the holder to purchase one share of Class A common stock at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be traded on the NYSE under the symbols “ACIC” and “ACIC WS,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The offering is expected to close on October 30, 2020, subject to customary closing conditions.

Cantor Fitzgerald & Co. is acting as the sole book-running manager of the offering. The underwriter has been granted a 45-day option to purchase up to an additional 7,500,000 units offered by the Company to cover over-allotments, if any.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on October 27, 2020. The offering is being made only by means of a prospectus, copies of which may be obtained by contacting Cantor Fitzgerald & Co., Attention Capital Markets, 499 Park Avenue, New York, NY 10022, or by e-mail at [email protected].

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Atlas Crest Investment Corp.

Atlas Crest Investment Corp. is a special purpose acquisition company formed for the purpose of effecting a merger, stock purchase or similar business combination with one or more businesses. The Company is sponsored by an affiliate of Moelis & Company, a leading global financial advisor to corporate executives, boards, entrepreneurs, financial sponsors and governments. The management team is led by Ken Moelis, as Chairman, and Michael Spellacy, as Chief Executive Officer, both of whom have had careers centered around identifying, evaluating and implementing organic and inorganic transformational growth and value creation initiatives across a broad range of industries. While the Company intends to evaluate opportunities in many sectors, it believes the diverse experience and extensive relationship network of its management team, board and sponsor will drive particularly attractive investment opportunities in certain high growth sectors including media, online gaming/sports betting, fintech/payments, healthcare, business services and disruptive consumer.

For more information, please visit

Forward-Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements, including the successful consummation of the Company’s initial public offering, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based, except as required by law.

Andrea Hurst

Atlas Crest Investment Corp.

T: +1 347 583 9705

[email protected]

Continue Reading


Washington Federal Announces 22 Cent Per Share Cash Dividend


Today, the Board of Directors of Washington Federal, Inc. (Nasdaq: WAFD) (the Company), parent company of Washington Federal Bank, National Association WaFd Bank announced a regular quarterly cash dividend of 22 cents per share. The dividend will be paid November 20th, 2020 to common stockholders of record as of November 6th, 2020. This will be Washington Federals 151st consecutive quarterly cash dividend.

Washington Federal, Inc. is the parent company of Washington Federal Bank, a national bank that operates 234 branches in Washington, Oregon, Idaho, Utah, Nevada, Arizona, Texas and New Mexico. Established in 1917, the bank provides consumer and commercial deposit accounts, financing for small to middle market businesses, commercial real estate and residential real estate, including consumer mortgages, home equity lines of credit and insurance products through a subsidiary. As of September 30, 2020, the Company reported $18.8 billion in assets, $13.8 billion in deposits and $2.0 billion in stockholders equity.

Important Cautionary Statements

The foregoing information should be read in conjunction with the financial statements, notes and other information contained in the Companys 2019 Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

This press release contains statements about the Companys future that are not statements of historical fact. These statements are forward looking statements for purposes of applicable securities laws and are based on current information and/or management’s good faith belief as to future events. The words believe, expect, anticipate, project, and similar expressions signify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance. By their nature, forward-looking statements involve inherent risk and uncertainties, which change over time; and actual performance could differ materially from those anticipated by any forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statement.

To find out more about WaFd Bank, please visit our website WaFd Bank uses its website to distribute financial and other material information about the Company.

Washington Federal, Inc.

Brad Goode 206-626-8178

[email protected]

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
gbafNews28 gbafNews28
News37 mins ago

PlanetWatch activates innovative air quality monitoring in two key Italian cities and announces grant from the Algorand Foundation

ST. GENIS-POUILLY, France, Oct. 28, 2020 /PRNewswire/ — PlanetWatch, a French startup which is leveraging the Algorand blockchain to build...

gbafNews28 gbafNews28
News46 mins ago

Atlas Crest Investment Corp. Announces Pricing of $500 Million Initial Public Offering

October 27, 2020 — Atlas Crest Investment Corp. (NYSE: ACIC.U, the “Company”) announced today that it priced its initial public...

gbafNews28 gbafNews28
News49 mins ago

Global Hemophilia Therapeutics Market- Featuring Bayer AG, CSL Ltd., F. Hoffmann-La Roche Ltd. Among Others

The hemophilia therapeutics market is poised to grow by USD 4.19 billion during 2020-2024 progressing at a CAGR of over...

gbafNews28 gbafNews28
News49 mins ago

Washington Federal Announces 22 Cent Per Share Cash Dividend

Today, the Board of Directors of Washington Federal, Inc. (Nasdaq: WAFD) (the Company), parent company of Washington Federal Bank, National...

gbafNews28 gbafNews28
News50 mins ago

KBRA Assigns Preliminary Ratings to Oportun Funding 2020-1, LLC

Kroll Bond Rating Agency (KBRA) assigns preliminary ratings to four classes of notes for Oportun Funding 2020-1, LLC (Oportun 2020-1),...

gbafNews28 gbafNews28
News57 mins ago

Shareholder Alert: Robbins LLP Announces That Cabot Oil and Gas Corporation (COG) is Being Sued for Misleading Shareholders

Shareholder rights law firm Robbins LLP announces that on October 5, 2020, a purchaser of Cabot Oil and Gas Corporation...

gbafNews28 gbafNews28
News60 mins ago

Leading Cybersecurity Expert Kate Fazzini Joins IMPACT! Podcast Guestlist

A lineup of impactful thought leaders, including leading cybersecurity expert Kate Fazzini, has been announced for the current season of...

gbafNews28 gbafNews28
News1 hour ago

Novālent Welcomes Keivan Mehrtbar as Senior Director of Global Regulatory Affairs

NovÄlent Biotech, Inc (˜NovÄlent), a US biotechnology engineering firm, welcomes Keivan Mehrtbar to its team as senior director of global...

gbafNews28 gbafNews28
News1 hour ago

Global Expansion of the World’s First Damage-Free Microfluidic Chip Cell Sorter With On-Chip Biotechnologies

PHC Corporation of North America (hereafter PHCNA) is proud to announce a new partnership with On-chip Biotechnologies (USA) Co., Ltd....

gbafNews28 gbafNews28
News1 hour ago

Bluescape Opportunities Acquisition Corp. Announces Pricing Of $575 Million Initial Public Offering

Bluescape Opportunities Acquisition Corp. (the Company or BOAC), today announced the pricing of its initial public offering of 57,500,000 units...